What Are The 5 Types Of Pulmonary Hypertension

There are five classified groups of pulmonary hypertension and each one has a different cause, a different mechanism and a completely different treatment approach. Group 1 is pulmonary arterial hypertension. Group 2 comes from left heart disease. Group 3 from lung disease. Group 4 from blood clots. Group 5 from mixed or unclear causes. Same name on the outside. Five completely different conditions underneath it.

“Calling it all pulmonary hypertension without knowing which group you’re in is like treating five different diseases with the same prescription. The type is everything,” says Dr. Prashant Bobhate, Pediatric Cardiologist in Mumbai, India.

Most people who get this diagnosis never hear the word group at all. They just hear pulmonary hypertension, walk out with a prescription and have genuinely no idea which version of this they’re actually sitting with.

• Group 1 pulmonary arterial hypertension: The lung artery walls themselves are the problem. They thicken, narrow and stiffen from the inside for reasons that include genetic mutations, connective tissue disease, congenital heart defects and sometimes no identifiable cause whatsoever which is what makes idiopathic PAH the hardest version of this group to sit with emotionally and clinically.
• Group 2 left heart disease: The most common type in adults and the one that gets misread most often. The left side isn’t pumping or filling properly and pressure backs up through the pulmonary veins into the lung circulation and what looks like a lung problem is actually a heart problem wearing completely the wrong label.
• Group 3 lung disease and low oxygen: COPD, interstitial lung disease, sleep apnoea. All of them damage lung tissue and drop oxygen levels over years until the pulmonary vessels start constricting in response and the pressure climbs in a way that compounds everything the underlying lung disease was already quietly doing.
• Why the group matters more than anything else: Group 1 medications like sildenafil and bosentan can actually worsen Group 2 pulmonary hypertension. Not slightly. Meaningfully. And giving the wrong treatment to the wrong group isn’t a minor error it’s something that makes things measurably and sometimes irreversibly worse.

That’s exactly why getting the group confirmed first is what makes the right pulmonary hypertension plan feel like something built specifically around your situation rather than a standard answer handed to everyone who walks in with the same two words on their referral letter.

Because these two get overlooked more than the others. Group 4 especially. And missing Group 4 matters enormously because it’s the one type of pulmonary hypertension where a genuine surgical cure is sitting right there waiting if someone actually looks for it properly.

• Group 4 chronic thromboembolic pulmonary hypertension: Old unresolved blood clots have scarred the pulmonary arteries and obstructed blood flow and this one is uniquely important because surgery called pulmonary endarterectomy can in many cases physically remove the obstruction and cure the condition outright in a way that no medication anywhere in the world can come close to matching.
• Group 5 mixed or unclear causes: Sarcoidosis, thyroid disorders, haematological diseases, metabolic conditions. All of them land here and this group doesn’t follow a clean treatment path because the underlying driver is genuinely different in every single patient who ends up in it and there’s no standard protocol that works across all of them.
• How Group 4 gets missed and what that costs: Right heart catheterisation combined with CTPA and ventilation perfusion imaging is what separates Group 4 from Group 1 properly. Skip that imaging and a patient who could have been surgically cured ends up on lifelong medication instead. That’s not a small consequence for anyone involved.
• Why Group 5 needs a different kind of thinking: Group 5 requires someone who can look at the whole clinical picture and connect conditions that don’t obviously belong together and that diagnostic instinct only comes from years spent specifically inside this field rather than from seeing it occasionally between other work.

Parents or adults wanting to understand what happens when pulmonary hypertension progresses regardless of the group should read this piece on when is lung transplant necessary for pulmonary hypertension which goes through honestly what the later stages look like and what options genuinely exist at each point along that road.

Getting the group right from the beginning isn’t something you want left to someone who sees pulmonary hypertension a handful of times a year and applies roughly the same approach to all of it. Dr. Prashant Bobhate chose this field deliberately. Spent over 12 years going deeper into every group and subtype of pulmonary hypertension than most cardiologists in India ever have. Trained at Escorts Heart Institute in New Delhi then went specifically to the University of Alberta in Canada just for advanced pulmonary hypertension fellowship training. His clinic is the only one in India running a real dedicated multidisciplinary pediatric pulmonary hypertension programme right now.

• Pulmonary Hypertension Types and Groups, National Heart Lung and Blood Institute — https://www.nhlbi.nih.gov/health/pulmonary-arterial-hypertension/causes
• Pulmonary Hypertension Overview, MedlinePlus, U.S. National Library of Medicine — https://medlineplus.gov/pulmonaryhypertension.html